Since lymphoma is a chemosensitive neoplasm, a complete response can be
May 12, 2019
Since lymphoma is a chemosensitive neoplasm, a complete response can be achieved by systemic chemotherapy, even in the metastatic setting. colon. Although a recent publication suggested the probability of lymphoma stem cells in non-Hodgkin lymphoma , it did not offer adequate data to support the presence of malignancy stem cells as an source of lymphoma. However, given the potential part of malignancy stem cells in the pathogenesis of cancers, the possibility of lymphoma stem cells deserves attention, for it could improve our understanding of lymphoma biology and lead to the development of a new restorative target for lymphomas. STEM CELLS IN HODGKIN LYMPHOMA A small human population of malignant cells, less than 1% of the total cells with this disease entity, is the hallmark of Hodgkin lymphoma. These malignant cells carry little phenotypic resemblance to normal B cells, including dim and variable CD20 manifestation. This unique nature of Hodgkin lymphoma offers suggested the living of lymphoma stem cells. A earlier study has demonstrated the presence of a small human population of CD20-positive B cells in 2 Hodgkin lymphoma cell GDC-0449 manufacturer lines, L428 and KM-H2 . These cells showed high manifestation of aldehyde dehydrogenase (ALDH), a marker for cells having stem-like properties as well as the memory space B-cell antigen CD27. The growth of Reed-Sternberg cells from an tradition of these B cells provides evidence for his or her stem cell-like house. These clonal B cells with CD27+, and elevated ALDH were also recognized in the peripheral blood of individuals with classic Hodgkin lymphoma, although their medical significance in Hodgkin lymphoma was not Rabbit polyclonal to ubiquitin identified with this study. These results consequently strengthen evidence for the living of lymphoma stem cells in Hodgkin lymphoma. STEM CELLS IN NON-HODGKIN LYMPHOMA Non-Hodgkin lymphoma refers to a group of heterogeneous disorders, including B cell and T/NK cell lymphomas. It is classified into numerous subtypes depending on the morphologic, immunophenotypic, and medical characteristics. These subtypes of non-Hodgkin lymphoma are associated with the specific developmental stages of the counterpart normal immune cells. For instance, errors in any of the immunoglobulin gene rearrangements during the developmental process of normal B cells may result in aberrant chromosomal translocations including immunoglobulin heavy chain genes, which are characteristic of different subtypes of B-cell non-Hodgkin lymphoma . This implies that a subset of cells having a genetic mistake occurring during their development might be an source of lymphoma, and suggests that they could play a role as lymphoma stem cells. However, the concept of malignancy stem cells would not necessarily imply that the transformation of normal stem cells GDC-0449 manufacturer constitutes the initiating step of carcinogenesis. If normal mature cells could acquire some properties of normal stem cells after their transformation into premalignant cells, they would re-express properties of stem cells, and then initiate cancers. Likewise, premalignant lymphoma cells might need additional genetic changes associated with stemness to become lymphoma stem cells. For example, the 1st chromosomal translocations could occur in mature lymphocytes within the germinal center, and these would need to accumulate secondary reprogramming mutations in order to develop germinal center-derived lymphomas. Part Human population CELLS IN HODGKIN AND NON-HODGKIN LYMPHOMAS Part population (SP) analysis has been used to exploit the presence of malignancy stem cells for cancers that have no surface marker GDC-0449 manufacturer for stem cell isolation. This analysis is based on the peculiar characteristic of normal stem cells that allows them to protect themselves from cytotoxic providers via high manifestation of ATP-binding cassette (ABC) transporters. Therefore, the SP is definitely a sub-population of cells that extrude the cell-permeable DNA-specific dye, Hoechst 33342, through an ABC transporter. The SP was recognized as a stem cell human population, distinguishable from additional such populations . Such a distinguishing house supports that notion that malignancy stem cells are associated with a resistance to chemotherapy and posttreatment relapse. Earlier studies in several human being and murine malignancy cell lines have shown that SP cells could be characterized as malignancy stem cells. In Hodgkin lymphoma, the possibility of lymphoma stem cell human population and the association of this population with resistance to chemotherapy have been reported. Therefore, Hodgkin lymphoma cell lines contain SP cells, which are enriched for unique small mononuclear GDC-0449 manufacturer cells and generate larger cells with Reed-Sternberg cell-like morphology . In addition, the SP cells in Hodgkin lymphoma cell lines display increased resistance to gemcitabine, a drug popular to treat refractory Hodgkin lymphoma . A study having a murine mantle cell lymphoma model also proposed GDC-0449 manufacturer that SP cells contain tumor-initiating.